Fibrocell Science Company Profile (NASDAQ:FCSC)

About Fibrocell Science

Fibrocell Science logoFibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FCSC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.72
  • 50 Day Moving Average: $0.90
  • 200 Day Moving Average: $1.63
  • 52-Week Range: $0.71 - $6.18
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.57
  • P/E Growth: 0.00
  • Market Cap: $31.61M
  • Outstanding Shares: 43,898,000
  • Beta: 0.45
Profitability:
  • Net Margins: -10,860.23%
  • Return on Equity: -124.33%
  • Return on Assets: -72.26%
Debt:
  • Current Ratio: 2.83%
  • Quick Ratio: 2.80%
Additional Links:
Companies Related to Fibrocell Science:

Analyst Ratings

Consensus Ratings for Fibrocell Science (NASDAQ:FCSC) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $5.63 (681.25% upside)

Analysts' Ratings History for Fibrocell Science (NASDAQ:FCSC)
Show:
DateFirmActionRatingPrice TargetDetails
8/7/2016Canaccord GenuityReiterated RatingBuy$1.50View Rating Details
7/6/2016Griffin SecuritiesReiterated RatingBuy$12.00View Rating Details
6/8/2016Roth CapitalReiterated RatingBuy$5.00View Rating Details
6/8/2016WedbushReiterated RatingNeutral$1.50 -> $4.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Fibrocell Science (NASDAQ:FCSC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.15)($0.18)ViewN/AView Earnings Details
5/5/2016Q1($0.15)($0.03)ViewN/AView Earnings Details
3/10/2016Q415($0.17)($0.40)ViewListenView Earnings Details
11/5/2015Q315($0.16)($0.07)ViewN/AView Earnings Details
8/6/2015Q215($0.16)($0.17)ViewN/AView Earnings Details
5/8/2015($0.16)($0.17)ViewN/AView Earnings Details
3/13/2015($0.16)($0.08)ViewN/AView Earnings Details
11/7/2014Q3 14($0.14)($0.17)ViewN/AView Earnings Details
8/11/2014($0.18)($0.08)ViewN/AView Earnings Details
5/19/2014Q114($0.15)($0.35)ViewN/AView Earnings Details
3/17/2014Q414($0.26)($0.14)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Fibrocell Science (NASDAQ:FCSC)
Current Year EPS Consensus Estimate: $-0.49 EPS
Next Year EPS Consensus Estimate: $-0.46 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.18)($0.14)($0.16)
Q2 20163($0.22)($0.09)($0.15)
Q3 20163($0.19)($0.06)($0.12)
Q4 20163($0.22)($0.07)($0.13)
Q1 20174($0.20)($0.07)($0.14)
Q2 20174($0.20)($0.07)($0.14)
Q3 20174($0.21)($0.05)($0.13)
Q4 20173($0.17)($0.05)($0.11)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Fibrocell Science (NASDAQ:FCSC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Fibrocell Science (NASDAQ:FCSC)
Insider Ownership Percentage: 3.70%
Institutional Ownership Percentage: 61.89%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/13/2015David PernockCEOBuy3,000$5.00$15,000.00View SEC Filing  
8/11/2015David PernockCEOBuy3,500$6.54$22,890.00View SEC Filing  
7/27/2015Randal J KirkMajor ShareholderBuy975,987$5.80$5,660,724.60View SEC Filing  
5/13/2015David PernockCEOBuy16,600$4.30$71,380.00View SEC Filing  
12/12/2014David PernockCEOBuy5,000$2.52$12,600.00View SEC Filing  
11/20/2014David PernockCEOBuy5,000$2.54$12,700.00View SEC Filing  
11/20/2014John Michael MaslowskiVPBuy1,000$2.54$2,540.00View SEC Filing  
6/5/2014Christine St.ClareDirectorBuy10,000$3.00$30,000.00View SEC Filing  
6/5/2014David PernockCEOBuy12,500$2.95$36,875.00View SEC Filing  
6/4/2014Kelvin MooreDirectorBuy4,557$2.99$13,625.43View SEC Filing  
6/4/2014Randal J KirkMajor ShareholderBuy400,000$2.90$1,160,000.00View SEC Filing  
1/24/2014Randal J KirkMajor ShareholderBuy1,024,590$4.88$4,999,999.20View SEC Filing  
11/21/2013David PernockCEOBuy10,000$3.69$36,900.00View SEC Filing  
11/20/2013Gregory L WeaverCFOBuy10,000$3.51$35,100.00View SEC Filing  
10/1/2013Randal J KirkMajor ShareholderBuy3,658,536$4.10$14,999,997.60View SEC Filing  
7/26/2013Randal J KirkMajor ShareholderBuy1,243,781$6.03$7,499,999.43View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Fibrocell Science (NASDAQ:FCSC)
DateHeadline
globenewswire.com logoFibrocell to Present at 2016 Cell & Gene Meeting on the Mesa - GlobeNewswire (press release) (NASDAQ:FCSC)
globenewswire.com - September 29 at 4:55 PM
News IconFibrocell Science Inc (FCSC) Updated Broker Price Targets - The De Soto Edge (NASDAQ:FCSC)
desotoedge.com - September 29 at 4:55 PM
finance.yahoo.com logoFibrocell to Present at 2016 Cell & Gene Meeting on the Mesa (NASDAQ:FCSC)
finance.yahoo.com - September 29 at 10:01 AM
News IconInterested Penny Stock Investors Keen on Shares of Fibrocell Science, Inc. (NASDAQ:FCSC) - Duncan Research (NASDAQ:FCSC)
www.duncanindependent.com - September 28 at 4:51 PM
News IconCurrent Price Targets For Fibrocell Science Inc (FCSC) - NewsDen (NASDAQ:FCSC)
newsden.net - September 28 at 4:51 PM
investornewswire.com logoCan Shares Of Fibrocell Science Inc (NASDAQ:FCSC) Hit $6? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - September 28 at 4:51 PM
News IconPenny Stock Investors are Growing Curious About Fibrocell Science, Inc. (NASDAQ:FCSC) - Duncan Research (NASDAQ:FCSC)
www.duncanindependent.com - September 28 at 9:53 AM
capitalcube.com logoETF’s with exposure to Fibrocell Science, Inc. : September 27, 2016 (NASDAQ:FCSC)
www.capitalcube.com - September 27 at 4:59 PM
News IconFibrocell Science Inc (FCSC) Receives Neutral Rating from Wedbush - DailyQuint (NASDAQ:FCSC)
dailyquint.com - September 23 at 9:58 AM
News IconUnder the Microscope, Zeroing in at Fibrocell Science, Inc. (NASDAQ:FCSC) - Duncan Research (NASDAQ:FCSC)
www.duncanindependent.com - September 23 at 9:58 AM
News IconPenny Stock Investors Take an Interest in Fibrocell Science, Inc. (NASDAQ:FCSC) - Duncan Research (NASDAQ:FCSC)
www.duncanindependent.com - September 21 at 9:13 AM
News IconFibrocell Science Incorporated (NASDAQ:FCSC) Sellers Covered 5.05% of Their Shorts - Post News (NASDAQ:FCSC)
www.kentuckypostnews.com - September 19 at 3:54 PM
streetinsider.com logoFibrocell Science (FCSC) Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 to Treat RDEB - StreetInsider.com (NASDAQ:FCSC)
www.streetinsider.com - September 19 at 3:54 PM
publicnow.com logoFibrocell Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa (NASDAQ:FCSC)
www.publicnow.com - September 19 at 9:39 AM
investornewswire.com logoCan Shares Of Fibrocell Science Inc (NASDAQ:FCSC) Hit $6 - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - September 16 at 8:45 AM
capitalcube.com logoETF’s with exposure to Fibrocell Science, Inc. : September 15, 2016 (NASDAQ:FCSC)
www.capitalcube.com - September 15 at 5:23 PM
News IconWhat's Propelling Fibrocell Science Inc to Reach 52-Week High? - Frisco Fastball (NASDAQ:FCSC)
friscofastball.com - September 14 at 9:10 AM
globenewswire.com logoFibrocell Announces Closing of $18 Million Private Placement - GlobeNewswire (press release) (NASDAQ:FCSC)
globenewswire.com - September 10 at 4:40 PM
seekingalpha.com logoFibrocell finalizes $18M convertible debt offering - Seeking Alpha (NASDAQ:FCSC)
seekingalpha.com - September 10 at 4:40 PM
bizjournals.com logoGene therapy company raises $18M (NASDAQ:FCSC)
www.bizjournals.com - September 9 at 4:51 PM
investornewswire.com logoFibrocell Science Inc (NASDAQ:FCSC) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - August 25 at 9:58 AM
capitalcube.com logoETF’s with exposure to Fibrocell Science, Inc. : August 23, 2016 (NASDAQ:FCSC)
www.capitalcube.com - August 23 at 5:07 PM
News IconShares Dipping Lower in Trade: Fibrocell Science, Inc. (NASDAQ:FCSC) - Post News (NASDAQ:FCSC)
www.kentuckypostnews.com - August 22 at 5:02 PM
investornewswire.com logoWill Fibrocell Science Inc (NASDAQ:FCSC) Hit $12 Price Target? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - August 18 at 5:37 AM
finance.yahoo.com logoFIBROCELL SCIENCE, INC. Financials (NASDAQ:FCSC)
finance.yahoo.com - August 13 at 4:53 PM
capitalcube.com logoETF’s with exposure to Fibrocell Science, Inc. : August 11, 2016 (NASDAQ:FCSC)
www.capitalcube.com - August 11 at 5:09 PM
News IconFibrocell Science Inc (NASDAQ:FCSC) & RR Donnelley & Sons Co (NASDAQ:RRD) Market Movers - Money News (press release) (NASDAQ:FCSC)
www.newsismoney.com - August 10 at 11:11 PM
streetinsider.com logoFibrocell Science (FCSC) Announces $25M Conv. Debt, Warrants Offering; Terminates Stock Offering (NASDAQ:FCSC)
www.streetinsider.com - August 10 at 12:22 PM
investors.com logoFibrocell Science relaunches funding with convertible debt not equity (NASDAQ:FCSC)
www.proactiveinvestors.com - August 10 at 12:22 PM
publicnow.com logoIntrexon Announces Second Quarter and First Half 2016 Financial Results (NASDAQ:FCSC)
www.publicnow.com - August 9 at 9:18 PM
streetinsider.com logoFibrocell Science (FCSC) Announces $25M Conv. Debt, Warrants Offering; Terminates Stock Offering - StreetInsider.com (NASDAQ:FCSC)
www.streetinsider.com - August 9 at 3:41 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia (NASDAQ:FCSC)
biz.yahoo.com - August 9 at 3:41 PM
finance.yahoo.com logo8:35 am Fibrocell Science terminates previously announced underwritten public offering, announces convertible debt and warrant financing for up to $25 mln (NASDAQ:FCSC)
finance.yahoo.com - August 9 at 3:41 PM
publicnow.com logoFibrocell Announces Convertible Debt and Warrant Financing of Up to $25 Million (NASDAQ:FCSC)
www.publicnow.com - August 9 at 3:41 PM
capitalcube.com logoFibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:FCSC)
www.capitalcube.com - August 9 at 3:41 PM
bizjournals.com logoGene therapy company scraps public stock offering for private financing (NASDAQ:FCSC)
www.bizjournals.com - August 9 at 3:41 PM
finance.yahoo.com logoFibrocell Announces Proposed Public Offering of Common Stock and Warrants (NASDAQ:FCSC)
finance.yahoo.com - August 8 at 5:06 PM
sg.finance.yahoo.com logoFibrocell Science reports 2Q loss (NASDAQ:FCSC)
sg.finance.yahoo.com - August 4 at 5:18 PM
News IconHC Stocks in Front Line: Fibrocell Science Inc (NASDAQ:FCSC), Pfizer Inc. (NYSE:PFE) - share market updates (press release) (NASDAQ:FCSC)
sharemarketupdates.com - August 2 at 9:50 AM
globenewswire.com logoPhase I Data Expected in the Second Half of 2017 (NASDAQ:FCSC)
globenewswire.com - July 29 at 5:03 PM
investornewswire.com logoCan Shares Of Fibrocell Science Inc (NASDAQ:FCSC) Hit $12? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - July 27 at 5:11 PM
publicnow.com logoFibrocell Announces First Subjects Enrolled in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa (NASDAQ:FCSC)
www.publicnow.com - July 27 at 4:28 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:FCSC)
biz.yahoo.com - July 27 at 4:08 PM
News IconChecking in on Stock Volatility for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily (NASDAQ:FCSC)
www.engelwooddaily.com - July 22 at 6:19 AM
News IconStock Soars, Rewards Investors Nicely Today: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily (NASDAQ:FCSC)
www.engelwooddaily.com - July 22 at 6:19 AM
investornewswire.com logoIs $12 Price Target Attainable For Fibrocell Science Inc (NASDAQ:FCSC)? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - July 21 at 8:32 AM
News IconHow Many Fibrocell Science Inc (NASDAQ:FCSC)'s Analysts Are Bearish? - Press Telegraph (NASDAQ:FCSC)
presstelegraph.com - July 21 at 8:32 AM
news.cmlviz.com logoFibrocell Science Inc Stock Technicals Hit Extreme Weakness - CML News (NASDAQ:FCSC)
news.cmlviz.com - July 19 at 5:06 PM
kcregister.com logoInovio Pharmaceuticals, Inc. (NASDAQ:INO) Rose 2.36%: Fibrocell Science, Inc. (NASDAQ:FCSC), Bank of America ... - KC Register (NASDAQ:FCSC)
www.kcregister.com - July 19 at 5:06 PM
News IconInvestor Watch: Volatility Recap on Shares of: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily (NASDAQ:FCSC)
www.engelwooddaily.com - July 19 at 5:06 PM

Social

Fibrocell Science (NASDAQ:FCSC) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff